Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Published in: Journal of Neuro-Oncology 2/2014

01-09-2014 | Topic Review

Prognostic awareness and communication of prognostic information in malignant glioma: a systematic review

Authors: Eli L. Diamond, Geoffrey W. Corner, Antonio De Rosa, William Breitbart, Allison J. Applebaum

Published in: Journal of Neuro-Oncology | Issue 2/2014

Login to get access

Abstract

Malignant glioma (MG) is a devastating neurological disease with a uniformly poor prognosis and a clinical course characterized by progressive functional and cognitive impairment. A small body of literature addresses patients’ and caregivers’ prognostic awareness (PA), or understanding of prognosis in patients with cancer. Studies that examine PA and desire for prognostic information among patients with MG are limited. We sought to review the existing literature on PA and communication of prognostic information to patients with MG. Fourteen studies examining PA or experience and preferences regarding communication of prognostic information were included. The definition and measurement of PA across studies varied, and the prevalence of accurate PA ranged from 25 to 100 % of participants. There is likely a subset of patients who do not desire accurate prognostic information, although the patient and disease characteristics that predict this preference are currently unknown. This review suggests that patients with MG desire prognostic information communicated in a manner that preserves hope. Systematic investigation to define communication needs for prognostic information in the unique clinical setting of MG is needed.
Literature
1.
Chochinov HM et al (2000) Prognostic awareness and the terminally ill. Psychosomatics 41(6):500–504PubMedCrossRef
2.
Dunn SM et al (1993) Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients. J Clin Oncol 11(5):989–996PubMed
3.
Lichtenthal WG et al (2009) Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches? Psychooncology 18(1):50–61PubMedCentralPubMedCrossRef
4.
Wright AA et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300(14):1665–1673PubMedCentralPubMedCrossRef
5.
Bradley EH et al (2001) Documentation of discussions about prognosis with terminally ill patients 111(3):218–223
6.
Mack JW et al (2006) Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol 24(33):5265–5270PubMedCrossRef
7.
Hebert RS et al (2009) Preparing family caregivers for death and bereavement. Insights from caregivers of terminally ill patients. J Pain Symptom Manag 37(1):3–12CrossRef
8.
Ray A et al (2006) Peaceful awareness in patients with advanced cancer. J Palliat Med 9(6):1359–1368PubMedCrossRef
9.
10.
11.
Fallowfield L, Ford S, Lewis S (1995) No news is not good news: information preferences of patients with cancer. Psychooncology 4(3):197–202PubMedCrossRef
12.
Mack JW, Smith TJ (2012) Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol 30(22):2715–2717PubMedCrossRef
13.
Lamont EB, Christakis NA (2001) Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134(12):1096–1105PubMedCrossRef
14.
Morasso G et al (1997) Illness awareness in cancer patients: a conceptual framework and a preliminary classification hypothesis. Psychooncology 6(3):212–217PubMedCrossRef
15.
Burns CM et al (2007) Fluctuating awareness of treatment goals among patients and their caregivers: a longitudinal study of a dynamic process. Support Care Cancer 15(2):187–196PubMedCrossRef
16.
17.
Davies E, Higginson IJ (2003) Communication, information and support for adults with malignant cerebral glioma: a systematic literature review. Support Care Cancer 11(1):21–29PubMed
18.
Fagg J et al (2008) Area social fragmentation, social support for individuals and psychosocial health in young adults: evidence from a national survey in England. Soc Sci Med 66(2):242–254PubMedCrossRef
19.
Davies E, Clarke C, Hopkins A (1996) Malignant cerebral glioma. 2. Perspectives of patients and relatives on the value of radiotherapy. Br Med J 313(7071):1512–1516CrossRef
20.
Anderson SI, Taylor R, Whittle IR (1999) Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 13(5):480–485PubMedCrossRef
21.
Salander P, Bergenheim T, Henriksson R (1996) The creation of protection and hope in patients with malignant brain tumours. Soc Sci Med 42(7):985–996PubMedCrossRef
22.
Lyons GJ (1996) The ‘PRESTON Profile’–the first disease-specific tool for assessing quality of life in patients with malignant glioma. Disabil Rehabil 18(9):460–468PubMedCrossRef
23.
Ward-Smith P (1997) Stereotactic radiosurgery for malignant brain tumors: the patient’s perspective. J Neurosci Nurs 29(2):117–122PubMedCrossRef
24.
Cavers D et al (2012) Social, psychological and existential well-being in patients with glioma and their caregivers: a qualitative study. CMAJ 184(7):E373–E382PubMedCentralPubMedCrossRef
25.
Diaz JL et al (2009) Proper information during the surgical decision-making process lowers the anxiety of patients with high-grade gliomas. Acta Neurochir (Wien) 151(4):357–362CrossRef
26.
Halkett GK et al (2010) The information and support needs of patients diagnosed with High Grade Glioma. Patient Educ Couns 79(1):112–119PubMedCrossRef
27.
Rosenblum ML et al (2009) Odyssey of hope: a physician’s guide to communicating with brain tumor patients across the continuum of care. J Neurooncol 92(3):241–251PubMedCrossRef
28.
Lobb EA, Halkett GKB, Nowak AK (2011) Patient and caregiver perceptions of communication of prognosis in high grade glioma. J Neurooncol 104(1):315–322PubMedCrossRef
29.
Janda M et al (2006) Supportive care needs of people with brain tumours and their carers. Support Care Cancer 14(11):1094–1103PubMedCrossRef
30.
Applebaum AJ et al. (2013) Optimism, social support, and mental health outcomes in patients with advanced cancer. Psychooncology
31.
Curtis JR et al (2008) An approach to understanding the interaction of hope and desire for explicit prognostic information among individuals with severe chronic obstructive pulmonary disease or advanced cancer. J Palliat Med 11(4):610–620PubMedCrossRef
32.
Salmon P et al (2012) Faith and protection: the construction of hope by parents of children with leukemia and their oncologists. Oncologist 17(3):398–404PubMedCentralPubMedCrossRef
33.
Prigerson HG (1992) Socialization to dying: social determinants of death acknowledgement and treatment among terminally ill geriatric patients. J Health Soc Behav 33(4):378–395PubMedCrossRef
34.
Gao X et al (2012) Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care. J Pain Symptom Manag 45(4):650–659CrossRef
35.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta analyses: the PRISMA statement. PLoS Med 6(6):e1000097. doi:10.​1371/​journal.​pmed1000097
Metadata
Title
Prognostic awareness and communication of prognostic information in malignant glioma: a systematic review
Authors
Eli L. Diamond
Geoffrey W. Corner
Antonio De Rosa
William Breitbart
Allison J. Applebaum
Publication date
01-09-2014
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2014
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-014-1487-1

Other articles of this Issue 2/2014

Journal of Neuro-Oncology 2/2014 Go to the issue

Laboratory Investigation

Aromatase and estrogen receptor alpha mRNA expression as prognostic biomarkers in patients with astrocytomas

Clinical Study

Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme

Topic Review

Detection of recurrent Cushing’s disease: proposal for standardized patient monitoring following transsphenoidal surgery

Laboratory Investigation

In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models

Clinical Study

Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study

Clinical Study

Combined salvage therapies for recurrent glioblastoma multiforme: evaluation of an interdisciplinary treatment algorithm